ci 988 has been researched along with asperlicin in 2 studies
| Studies (ci 988) | Trials (ci 988) | Recent Studies (post-2010) (ci 988) | Studies (asperlicin) | Trials (asperlicin) | Recent Studies (post-2010) (asperlicin) |
|---|---|---|---|---|---|
| 147 | 8 | 14 | 37 | 0 | 2 |
| Protein | Taxonomy | ci 988 (IC50) | asperlicin (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 1.4 | |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | 1.4 | |
| Cholecystokinin receptor type A | Homo sapiens (human) | 1.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohtsuka, T; Yokose, K | 1 |
| de Tullio, P; Delarge, J; Pirotte, B | 1 |
2 review(s) available for ci 988 and asperlicin
| Article | Year |
|---|---|
[Cholecystokinin receptor antagonists].
Topics: Amino Acid Sequence; Animals; Benzodiazepinones; Cholecystokinin; Furans; Indoles; Meglumine; Molecular Sequence Data; Proglumide; Receptors, Cholecystokinin; Sincalide; Thiophenes | 1993 |
Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Humans; Indoles; Keto Acids; Ligands; Meglumine; Peptoids; Proglumide; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Spiro Compounds; Structure-Activity Relationship; Tetragastrin | 1999 |